Dr T M A Pai Hospital, Udupi, has introduced advanced hearing and balance tests to help diagnose and treat hearing loss and balance problems. The department of speech and hearing now offers Auditory ...
Otolith Labs, a medical technology company developing prescription medical devices for the treatment of vestibular disorders, ...
Vestibular schwannomas, or acoustic neuromas, are noncancerous tumors that develop on the nerve leading from the inner ear to ...
Unfounded cancer cures, dubious anti-vaccine narratives, and false claims that neurological disorders can be "reversed" through diets: influential American and European podcasters are peddling ...
Course- based Undergraduate Research Experiences (CUREs) by incorporating nine essential elements of research, relevance, scientific background, hypothesis development, research proposal, all aspects ...
A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...
The recovery can extend from anywhere between six to 12 months and occasionally up to three years. Currently, there is no certain cure for Guillain-Barré Syndrome. The paralysis not only affects the ...
Therapists use a patient-centered approach to create customized treatment programs that thoroughly address each person's condition and help them achieve their rehabilitation goals.
One explanation of cybersickness is that it is a physiological responses to perceived differences between the visual and vestibular stimulation provided via VR technology and the user’s current body ...
As you age, less estrogen also means less moisture in your vaginal walls. There are no natural "cures" for age-related vaginal dryness, but there are some ways to increase wetness naturally. Any ...
While more medical interventions, such as a true cure for HIV or a vaccine for the disease (which is likely still years, if not decades, away), would help, this is no longer really a problem of ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results